Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Debt to Equity (2023 - 2024)

Historic Debt to Equity for Iovance Biotherapeutics (IOVA) over the last 5 years, with Q4 2024 value amounting to $0.0.

  • Iovance Biotherapeutics' Debt to Equity fell 1770.71% to $0.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $0.0, marking a year-over-year decrease of 1770.71%. This contributed to the annual value of $0.0 for FY2024, which is 1770.71% down from last year.
  • As of Q4 2024, Iovance Biotherapeutics' Debt to Equity stood at $0.0, which was down 1770.71% from $0.0 recorded in Q1 2024.
  • In the past 5 years, Iovance Biotherapeutics' Debt to Equity registered a high of $0.0 during Q2 2023, and its lowest value of $0.0 during Q4 2024.